RAPT Stock Latest News

RAPT Therapeutics Completes Acquisition and Transitions to Private Ownership

PremiumCompany Announcements

10d ago

RAPT Earnings Report this Week: Is It a Buy, Ahead of Earnings?

PremiumPre-Earnings

10d ago

Clear Street says AbbVie move further validates Oruka Therapeutics’ strategy

PremiumThe Fly

1M ago

Rapt Therapeutics downgraded to Equal Weight from Overweight at Barclays

ABBV

PremiumThe Fly

2M ago

PremiumThe FlyRapt Therapeutics downgraded to Market Perform from Outperform at Leerink

2M ago

The Fly

Rapt Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo

2M ago

The Fly

Rapt Therapeutics downgraded to Hold from Buy at TD Cowen

2M ago

Rapt downgraded to Market Perform from Outperform at LifeSci Capital

PremiumThe Fly

2M ago

Midday Fly By: Netflix and Warner amend deal, GSK to acquire Rapt

PremiumThe Fly

2M ago

PremiumThe Fly

Rapt Therapeutics downgraded to Neutral from Buy at H.C. Wainwright

2M ago

Rapt Therapeutics downgraded to Neutral from Buy at Guggenheim

PremiumThe Fly

2M ago

PremiumThe FlyRapt Therapeutics downgraded to Neutral from Overweight at Piper Sandler

2M ago

The Fly

Rapt Therapeutics downgraded to Hold from Buy at Clear Street

2M ago

Company Announcements

GSK to Acquire RAPT Therapeutics in Cash Merger

2M ago

GSK to acquire Rapt Therapeutics for $58.00 per share

PremiumThe Fly

2M ago

M&A News: GSK Bets Big on Food Allergy Drugs with $2.2B RAPT Therapeutics Deal

PremiumMarket News

2M ago

RAPT Therapeutics Showcases Ozureprubart Progress, Strengthened Outlook

PremiumCompany Announcements

2M ago

Rapt Therapeutics initiated with an Overweight at Piper Sandler

PremiumThe Fly

2M ago

PremiumRatingsRAPT Therapeutics: De-Risked ‘Bio-Better’ Ozureprubart Underpins Buy Rating and Upside to Target Price

2M ago

The Fly

Rapt Therapeutics initiated with a Buy at TD Cowen

3M ago

Ratings

RAPT Therapeutics: Promising Pipeline and Superior Efficacy of Lead Candidate Ozureprubart

3M ago